VXRT News and Press, Vaxart Inc. From 05/01/21

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks fell broadly Friday, as investors took profits following a flurry of earnings reports, including a blowout quarter from Amazon, and an...

Vaxart stock has gained 54% over the past month as the company continues to press its case for an oral COVID vaccine. Its phase 1 trial results were considered disappointing but Vaxart has issued a robust response. The company is still under investigation for possibly making misle...

Vaxart (VXRT), which is developing an oral COVID-19 vaccine, is up more than 9% to $9.21 in afternoon trading as chatter on the Wall Street Bets Reddit channel heats up and the company announced its founder will present at a major vaccines conference.Sean Tucker, who is also chief s...

SOUTH SAN FRANCISCO, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its founder and chief scientific officer, S...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the stock market today! For investors, an upcoming policy decision from the Federal Reserve is a key factor this morning. Earnings from tech giants like Microsoft (NASDAQ: MSFT ) are also m...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the largest roadblocks in the progress toward Covid-19 reopening is the seemingly endless cropping up of new strains. Now, with a coming webinar hosted by Vaxart (NASDAQ: VXRT ), we might be looking at treatmen...

Vaxart ([[VXRT]] +46.5%) shares are on the rise today, and if the rally holds the stock appears to be on course to post its highest one-day gain since early February.So far 150.7M Vaxart shares have changed hands more than 11 times the 65-day average volume at ~13.4M.Despite the resignation o...

Gainers: Tian Ruixiang (TIRX) +54%.Vaxart (VXRT) +51%.RiceBran Technologies (RIBT) +47%.Aldeyra Therapeutics (ALDX) +31%.NetSol Technologies (NTWK) +30%.First Choice Bancorp (FCBP) +28%.TrueBlue (TBI) +26%.Brooklyn ImmunoTherapeutics (BTX) +23%.Big Rock Partners Acquisition (BRPA) +23%.T...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clinical-stage biotechnology company Vaxart  (NASDAQ: VXRT ), as the name implies, is known for developing vaccines. There are other, more famous coronavirus vaccine makers out there, but VXRT stock is cheap and m...

Vaxart to provide new data from its Phase I COVID-19 trial Stanford University T-cell expert to discuss cross-protection against variants SOUTH SAN FRANCISCO, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing ...